Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
39.83
+1.58 (4.13%)
At close: Dec 5, 2025, 4:00 PM EST
39.51
-0.32 (-0.80%)
After-hours: Dec 5, 2025, 7:36 PM EST
HRMY Market Cap
HRMY has a market cap or net worth of $2.29 billion as of December 5, 2025. Its market cap has increased by 21.63% in one year.
Market Cap
2.29B
Enterprise Value
1.79B
1-Year Change
21.63%
Ranking
Category
Stock Price
$39.83
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $2.29B, an increase of 397.59%. That is a compound annual growth rate of 35.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 2.20B | 12.26% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | 2.06B | 346.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 912.41B |
| Johnson & Johnson | 491.45B |
| AbbVie | 407.03B |
| UnitedHealth Group | 302.96B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 252.12B |
| Abbott Laboratories | 216.85B |